Previous Close | 86.20 |
Open | 87.52 |
Bid | 101.15 x 20000 |
Ask | 102.20 x 20000 |
Day's Range | 87.52 - 99.64 |
52 Week Range | 41.20 - 99.64 |
Volume | |
Avg. Volume | 248 |
Market Cap | 6.457B |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -7.81 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 119.00 |
Q1 2024 Blueprint Medicines Corp Earnings Call
Detailed Analysis of Financial Performance and Strategic Updates
Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 19.51% and 16.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?